БЛОГ

Archive for the ‘biotech/medical’ category: Page 1681

Apr 3, 2020

Jeff Bezos’ space company is pressuring employees to launch a tourist rocket during the pandemic

Posted by in categories: biotech/medical, health, space travel

Employees at Jeff Bezos’ aerospace firm Blue Origin are outraged that senior leadership is pressuring workers to conduct a test launch of the company’s New Shepard rocket — designed to take wealthy tourists into space — while the COVID-19 pandemic devastates the United States.

To conduct the flight, Blue Origin officials are considering transporting employees from the company’s main headquarters in Kent, Washington — a town near Seattle where COVID-19 cases have surged — to a small town in West Texas called Van Horn. The town, which has a population of just over 2,000, is home to Blue Origin’s test launch facility where the company has conducted all past flights of the New Shepard rocket.

Many employees fear that traveling to Van Horn might expose them to the novel coronavirus and inadvertently introduce COVID-19 to the residents of the rural town where there is very little infrastructure to handle an outbreak. The Verge spoke exclusively with four Blue Origin employees who all asked to remain anonymous for fear of retaliation from the company. They say they are frustrated by the company’s desire to conduct a launch, as it could unnecessarily jeopardize the health of employees at Blue Origin and residents of Van Horn.

Apr 3, 2020

The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro

Posted by in category: biotech/medical

Shared by Michael Michalchik

Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro.

• A single treatment able to effect ∼5000-fold reduction in virus at 48h in cell culture.

Continue reading “The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro” »

Apr 3, 2020

Makers Vs Covid

Posted by in categories: biotech/medical, materials

Our goal is to evaluate, test and share the validated & most promising Maker projects to create an alternative system to supply medical materials.

Apr 3, 2020

‘Rebooting the brain’: Our fight to bring people back from the dead

Posted by in categories: biotech/medical, computing, neuroscience

Studies of hibernating animals suggest that the molecular and synaptic integrity of neurons in the cerebral cortex that underlie self and consciousness is maintained in many cases when from the outside the brain appears dead.


A striking feature of medicine over the past few centuries has been our growing ability to bring people back from the “dead.” For most of human history, patients who were unconscious and not breathing were treated as though they had died. But the concept of resuscitation emerged as doctors grew to understand the basic function of the lungs and airways. That led to new techniques and tools capable of restoring both breathing and heartbeat — and the realization that cardiac arrest was not always a death sentence. That, in turn, gave rise to a distinction between what’s now called clinical death versus brain death.

Continue reading “‘Rebooting the brain’: Our fight to bring people back from the dead” »

Apr 3, 2020

Cellex and Mayo Clinic Launch Tests to Determine COVID-19 Immunity from Previous Exposure

Posted by in categories: biotech/medical, health

The U.S. Food and Drug Administration (FDA) approved the first blood test that looks for the antibodies against the novel coronavirus that causes COVID-19. This is different than assays that test for presence of the virus—those test to determine if a patient has COVID-19. These new antibody tests determine if the person was exposed to the virus, had COVID-19 and recovered. And it suggests, if positive, that the person is now immune to COVID-19 and can’t get it again.

Research Triangle Park, North Carolina-based Cellex was granted an emergency use authorization (EUA) on its test yesterday.

The test is performed on a blood sample taken from a patient’s vein and can be performed by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), the Health and Human Services division that oversees clinical diagnostic testing in the United States.

Apr 3, 2020

UH professor develops coating that protects PPE from droplets that spread COVID-19

Posted by in categories: biotech/medical, health

HOUSTON — A University of Houston professor is waiting for FDA approval of a waterproofing solution that he says can shield personal protective equipment such as N95 masks from the droplets that spread COVID-19.

Professor Seamus Curran said he developed the hydrophobic coating in 2011 while testing it on fabrics. He continued creating similar solutions to be used on wood and masonry with his company, Integricote.

When COVID-19 broke out, he felt the coating could help, especially as health care workers warned of a nationwide shortage of personal protective equipment (PPE) such as N95 masks that health care workers wear.

Apr 3, 2020

Coronavirus Delivers ‘World’s First’ Drone Delivery Service

Posted by in categories: biotech/medical, drones, food

Coronavirus is sending in the drones. In what’s being billed as a “world first,” startup Manna Aero has begun a drone delivery service in Moneygall, Ireland. Delivering medicine to vulnerable people locked in their homes, it provides yet another strong example of how technology is helping the world adjust to life in the shadow of the coronavirus.

Having received authorisation from the Irish Aviation Authority, Manna Aero’s service began last Friday as a pilot in Moneygall, which was previously best known as Barack Obama’s ancestral village. However, if the trial is successful, the service will be rolled out throughout Ireland, and could also be used to deliver food.

The drones will deliver prescription orders for medicine to around a dozen households. As Manna Zero’s founder Bobby Healy told the Irish Independent, the drones ensure “zero human-contact” and can execute deliveries “in ways normal delivery can’t.”

Apr 3, 2020

Researchers determine how the p53 protein can lead cancer cells to their death

Posted by in category: biotech/medical

There is an ongoing battle between cancer cells and p53, the protein known as “the guardian of the genome,” and a study conducted at the University of Trento has identified a number of factors that influence the outcome of this battle and therefore the effectiveness of cancer treatments.

Scientists explore two therapeutic treatment scenarios: In one scenario, stop proliferating; in the other, their death rate increases. Both of these outcomes are regulated the protein p53. Based on the new findings, a specific factor, a protein known as DHX30, determines how p53 can lead cancer cells to their death. That is the conclusion reached by a team of researchers of the University of Trento, who focused on a new molecular mechanism that works like a switch.

Erik Dassi, member of the research team, said, “When cancer cells are treated with a certain drug, it is the action of this switch (DHX30) that makes them to go toward cell and not in the direction of cell cycle arrest.”

Apr 3, 2020

5G coronavirus conspiracists BURNING phone masts amid bizarre claim ‘radiation’ sparked killer bug

Posted by in categories: biotech/medical, health, internet, mobile phones

🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️


CONSPIRACY nuts are reportedly setting phone masts alight and targeting engineers after a bizarre claim 5G “radiation” caused the deadly coronavirus spread.

The theory originated last month after a video filmed at a US health conference claimed Africa was not as affected by the disease because it is “not a 5G region”.

Continue reading “5G coronavirus conspiracists BURNING phone masts amid bizarre claim ‘radiation’ sparked killer bug” »

Apr 3, 2020

Special report: The simulations driving the world’s response to COVID-19

Posted by in categories: biotech/medical, computing, mathematics

Governments across the world are relying on mathematical projections to help guide decisions in this pandemic. Computer simulations account for only a fraction of the data analyses that modelling teams have performed in the crisis, Ferguson notes, but they are an increasingly important part of policymaking. But, as he and other modellers warn, much information about how SARS-CoV-2 spreads is still unknown and must be estimated or assumed — and that limits the precision of forecasts. An earlier version of the Imperial model, for instance, estimated that SARS-CoV-2 would be about as severe as influenza in necessitating the hospitalization of those infected. That turned out to be incorrect.


How epidemiologists rushed to model the coronavirus pandemic.